Acute kidney injury: Difference between revisions

(Text replacement - "Esp " to "Especially")
(Text replacement - "B-blocker" to "beta-blocker")
Line 70: Line 70:
***Valvulopathy
***Valvulopathy
**Pharmacologic
**Pharmacologic
***B-blockers
***beta-blockers
***CCBs
***CCBs
***Antihypertensive medications
***Antihypertensive medications

Revision as of 15:10, 1 August 2016

Background

  • Majority of cases of community-acquired ARF is secondary to volume depletion

RIFLE Classification

  • Risk - Serum Cr increased 1.5x baseline
  • Injury - Serum Cr increased 2.0x baseline
  • Failure - Serum Cr increased 3.0x baseline OR Cr >4 and acute increase >0.5
  • Loss - Complete loss of kidney function for >4wk
  • ESRD - Need for renal replacement therapy for >3mo

Chronic Kidney Disease Stages

  • Useful if patient's baseline creatinine is unknown
    • Stage 1: Kidney damage (e.g. proteinuria) and normal GFR; GFR >90
    • Stage 2: Kidney damage (e.g. proteinuria) and mild decrease in GFR; GFR 60-89
    • Stage 3: Moderate decrease in GFR; GFR >30-59
    • Stage 4: Severe decrease in GFR; GFR 15-29
    • Stage 5: Kidney failure (dialysis or kidney transplant needed); GFR <15

Risk Factors

Clinical Features

  • Acute renal failure itself has few symptoms until severe uremia develops:
  • Patients more likely to present with symptoms related to underlying cause:
    • Prerenal
      • Thirst, orthostatic light-headedness, decreasing urine output
    • Intrinsic
    • Postrenal
      • Alternating oliguria and polyuria is pathognomonic of obstruction
      • Anuria

Etiologies

Differential Diagnosis of Acute Kidney Injury.png

Prerenal

  • Hypovolemia
    • GI: decreased intake, vomiting and diarrhea
    • Pharmacologic: diuretics
    • Third spacing
    • Skin losses: fever, burns
    • Miscellaneous
      • Hypoaldosteronism
      • Salt-losing nephropathy
      • Postobstructive diuresis
  • Hypotension
    • Septic vasodilation
    • Hemorrhage
    • Decreased cardiac output
      • Ischemia/infarction
      • Valvulopathy
    • Pharmacologic
      • beta-blockers
      • CCBs
      • Antihypertensive medications
    • High-output failure
  • Renal artery and small-vessel disease
    • Embolism: thrombotic, septic, cholesterol
    • Thrombosis: atherosclerosis, vasculitis, sickle cell disease
    • Dissection
    • Pharmacologic
      • NSAIDs
      • ACEI/ARB
        • Observed shortly after initiation of therapy
    • Microvascular thrombosis
      • Preeclampsia
      • HUS
      • DIC
      • vasculitis
      • SCD
    • Hypercalcemia

Intrinsic

  • Tubular diseases
    • Ischemic acute tubular necrosis
      • Caused by more advanced disease due to the prerenal causes
  • Nephrotoxins
    • Aminoglycosides, radiocontrast, amphotericin B, heme pigments (rhabdomyolysis, hemolysis)
    • Obstruction
      • Uric acid, calcium oxalate, myeloma, amyloid
      • Pharmacologic: sulfonamide, triamterene, acyclovir, indinavir
  • Interstitial diseases
    • Acute interstitial nephritis: typically a drug reaction (NSAIDs, antibiotics, phenytoin)
    • Infection: bilateral pyelonephritis, Legionnaire disease, hantavirus
    • Infiltrative disease: sarcoidosis, lymphoma
    • Autoimmune diseases: SLE
  • Glomerular diseases
    • Rapidly progressive glomerulonephritis
      • Goodpasture, granulomatosis with polyangiitis (Wegener's) HSP, SLE, membranoproliferative GN
    • Postinfectious glomerulonephritis
  • Small-vessel diseases
    • Microvascular thrombosis
      • Preeclampsia, HUS, DIC, TTP, vasculitis (PAN, SCD, atheroembolism)
    • Malignant hypertension
    • Scleroderma
    • Renal vein thrombosis

Postrenal

  • Infants and children
    • Urethra and bladder outlet
      • Anatomic malformations
        • Urethral atresia
        • Meatal stenosis
        • Anterior and posterior urethral valves
    • Ureter
      • Anatomic malformations
        • Vesicoureteral reflux (female preponderance)
        • Ureterovesical junction obstruction
        • Ureterocele
        • Retroperitoneal tumor
  • All ages
    • Various locations in GU tract
      • Trauma
      • Blood clot
    • Urethra and bladder outlet
      • Phimosis or urethral stricture (male preponderance)
      • Neurogenic bladder
        • DM, spinal cord disease, multiple sclerosis, Parkinson's
        • Pharmacologic: anticholinergics, a-adrenergic antagonists, opioids
  • Adults
    • Urethra and bladder outlet
      • BPH
      • Cancer of prostate, bladder, cervix, or colon
      • Obstructed catheters
    • Ureter
      • Calculi, uric acid crystals
      • Papillary necrosis
        • SCD, DM, pyelonephritis
      • Tumor: Ureter, uterus, prostate, bladder, colon, rectum; retroperitoneal lymphoma
      • Retroperitoneal fibrosis: idiopathic, tuberculosis, sarcoidosis, propranolol
      • Stricture: TB, radiation, schistosomiasis, NSAIDs
      • Miscellaneous
        • Aortic aneurysm
        • Pregnant uterus
        • IBD
        • Trauma

Evaluation

  • Prerenal
    • BUN/Cr ratio > 20
    • FeNa <1% ((urine sodium/plasma sodium) / (urine creatinine / serum creatinine))
      • < 2% for neonates
    • Urine osm >500
    • Urine sodium < 20 mEq/L
    • Specific gravity > 1.020
    • Fractional excretion of urea < 35%
    • Microscopic analysis
      • Hyaline casts
  • Instrinsic
    • FeNa >1%
      • > 2.5% for neonates
    • Urine Osm <350
    • Urine sodium > 40 mEq/L
    • Specific gravity < 1.020
    • Fractional excretion of urea > 50%
    • Microscopic analysis
      • Acute glomerulonephritis: RBCs, casts
      • Acute tubular necrosis: protein, tubular epithelial cells
  • Postrenal
    • FeNa >1%
    • Urine Osm <350

Work-up

  • Urine
  • Prostate exam
  • UA, urine sodium, urine creatinine, urine urea
  • ECG (hyperkalemia)

Imaging

  • CXR
  • Evidence of volume overload, pneumonia
  • US
    • Test of choice in setting of acute renal failure
    • Bladder size (post-void)
    • Hydronephrosis
    • IVC collapsibility (prerenal)
  • CT
    • Useful to determine cause of post renal failure (identification of abdominal masses etc.)
    • Should generally not be used with IV contrast due to potential risk for CIN
    • Indicated if hydronephrois found on US in order to define the location of obstruction

Management

Treat underlying cause

  • Prerenal: IVF
  • Intrinsic: Depends on cause
  • Obstruction:
    • Note: Postobstructive diuresis can result in significant volume loss and death
      • Typically occurs when obstruction has been prolonged / has resulted in renal failure
      • Admit patients with persistent diuresis of >250 mL/h for >2hr
    • Foley Catheter, consider Coude Catheter
    • Suprapubic (if Coude fails)

Dialysis

  • Indicated for:
    • A: Acidosis (severe)
    • E: Electrolyte abnormality (e.g. uncontrolled hyperkalemia)
    • I: Ingestions (lithium, ASA, methanol, ethylene glycol, theophylline)
    • O: Overload (volume) with persistent hypoxia
    • U: Uremic pericarditis/encephalopathy/bleeding dyscrasia
    • Also:
      • Na <115 or >165 mEq/L
      • Cr > 10
      • BUN >100

Disposition

  • Admit

See Also


External Links

References